Skip to main content
Premium Trial:

Request an Annual Quote

LabVantage, InforSense Collaborate on LIMS

NEW YORK (GenomeWeb News) – LabVantage Solutions said today that it has forged an alliance with InforSense, under which the InforSense platform will be integrated with LabVantage’s Sapphire laboratory information management suite.
In addition, LabVantage will resell InforSense along with the Sapphire LIMS.
“Sapphire’s operational workflow and data management capabilities coupled with InforSense’s integration and analytics workflow capabilities offer customers a robust, yet flexible enterprise backbone for laboratory informatics,” Ronald Kasner, vice president of corporate development for LabVantage, said in a statement.
Bridgewater, NJ-based LabVantage said that it is demonstrating the Sapphire BioBanking solution with the integrative analytics of InforSense’s ClinicalSense Module at the Bio-IT World Congress this week in Boston.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.